Abstract
A 65-years-old woman with a refractory Multiple Myeloma (MM) treated with Daratumumab in combination with Lenalidomide and Dexamethasone (DRd) was admitted to our Neurology Unit for the subacute onset of left upper limb weakness, ataxia, and dysarthria.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
